Free Trial
NASDAQ:ATEC

Alphatec (ATEC) Stock Price, News & Analysis

Alphatec logo
$10.90 -0.18 (-1.58%)
As of 10:12 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Alphatec Stock (NASDAQ:ATEC)

Key Stats

Today's Range
$10.95
$11.13
50-Day Range
$10.64
$13.03
52-Week Range
$4.88
$13.14
Volume
162,809 shs
Average Volume
2.06 million shs
Market Capitalization
$1.59 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$17.89
Consensus Rating
Moderate Buy

Company Overview

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

Alphatec Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

ATEC MarketRank™: 

Alphatec scored higher than 84% of companies evaluated by MarketBeat, and ranked 149th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alphatec has received a consensus rating of Moderate Buy. The company's average rating score is 2.89, and is based on 8 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Alphatec has only been the subject of 4 research reports in the past 90 days.

  • Read more about Alphatec's stock forecast and price target.
  • Earnings Growth

    Earnings for Alphatec are expected to grow in the coming year, from ($1.08) to ($0.65) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alphatec is -9.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alphatec is -9.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Alphatec's valuation and earnings.
  • Percentage of Shares Shorted

    11.44% of the float of Alphatec has been sold short.
  • Short Interest Ratio / Days to Cover

    Alphatec has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Alphatec has recently increased by 2.88%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Alphatec does not currently pay a dividend.

  • Dividend Growth

    Alphatec does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    11.44% of the float of Alphatec has been sold short.
  • Short Interest Ratio / Days to Cover

    Alphatec has a short interest ratio ("days to cover") of 7.
  • Change versus previous month

    Short interest in Alphatec has recently increased by 2.88%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Alphatec has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Alphatec this week, compared to 6 articles on an average week.
  • Search Interest

    1 people have searched for ATEC on MarketBeat in the last 30 days.
  • MarketBeat Follows

    3 people have added Alphatec to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alphatec insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,633,172.00 in company stock.

  • Percentage Held by Insiders

    22.80% of the stock of Alphatec is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    66.35% of the stock of Alphatec is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Alphatec's insider trading history.
Receive ATEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alphatec and its competitors with MarketBeat's FREE daily newsletter.

ATEC Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

ATEC Stock Analysis - Frequently Asked Questions

Alphatec's stock was trading at $9.18 on January 1st, 2025. Since then, ATEC shares have increased by 18.8% and is now trading at $10.9050.
View the best growth stocks for 2025 here
.

Alphatec Holdings, Inc. (NASDAQ:ATEC) released its quarterly earnings results on Thursday, May, 1st. The medical technology company reported ($0.35) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.23. The firm's revenue was up 22.2% compared to the same quarter last year.
Read the conference call transcript
.

Shares of ATEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alphatec investors own include Invesco QQQ (QQQ), SPDR S&P 500 ETF Trust (SPY), SPDR Dow Jones Industrial Average ETF Trust (DIA), Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Meta Platforms (META).

Company Calendar

Last Earnings
5/01/2025
Today
6/30/2025
Next Earnings (Estimated)
7/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ATEC
Employees
700
Year Founded
1990

Price Target and Rating

Average Stock Price Target
$17.89
High Stock Price Target
$21.00
Low Stock Price Target
$15.00
Potential Upside/Downside
+61.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
9 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$162.12 million
Pretax Margin
-25.76%

Debt

Sales & Book Value

Annual Sales
$611.56 million
Price / Cash Flow
N/A
Book Value
($0.10) per share
Price / Book
-110.80

Miscellaneous

Free Float
112,846,000
Market Cap
$1.62 billion
Optionable
Optionable
Beta
1.10

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ATEC) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners